Why the study?
Does prophylactic administration of antiarrhythmic agents reduce mortality from sudden arrhythmias in ambulatory patients with coronary heart disease?
Does prophylactic administration of antiarrhythmic agents reduce mortality from sudden arrhythmias in ambulatory patients with coronary heart disease?
This review highlights the need for large-scale, controlled, prospective studies to evaluate the effectiveness of prophylactic antiarrhythmic therapy in ambulatory patients with coronary heart disease.
No takes yet. Share an insight, caveat, or question.
Evidence inadequate to guide prophylactic antiarrhythmic use in ambulatory CHD; leaves open mortality benefit pending large prospective trials.
Jan Koch‐Weser (1972) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: